doi: 10.2105/ajph.85.8_pt_1.1128.
Hormonal replacement therapy and morbidity and mortality in a prospective study of postmenopausal women
Affiliations
- PMID: 7625511
- PMCID: PMC1615815
- DOI: 10.2105/ajph.85.8_pt_1.1128
Item in Clipboard
Hormonal replacement therapy and morbidity and mortality in a prospective study of postmenopausal women
Am J Public Health.
1995 Aug.
Abstract
We assessed the association of hormonal replacement therapy with mortality and incidence of multiple diseases in over 40,000 postmenopausal women followed for 6 years as part of the Iowa Women's Health Study. Compared with women who never used hormone replacement therapy, current users had multivariate adjusted relative risks (RR) as follows: total mortality (RR = 0.78; 95% confidence interval [CI] = 0.65, 0.94), coronary heart disease mortality (RR = 0.74; 95% CI = 0.48, 1.12), endometrial cancer incidence (RR = 4.3; 95% CI = 2.7, 6.9), breast cancer incidence (RR = 1.23; 95% CI = 0.99, 1.55), colon cancer incidence (RR = 0.72; 95% CI = 0.46, 1.12), and hip fracture incidence (RR = 0.53; 95% CI = 0.31, 0.91).
Similar articles
-
Cardiovascular and cancer morbidity and mortality and sudden cardiac death in postmenopausal women on oestrogen replacement therapy (ERT).Lancet. 1998 Dec 19-26;352(9145):1965-9. doi: 10.1016/S0140-6736(98)05066-1. Lancet. 1998. PMID: 9872245
-
Adherence to the AICR cancer prevention recommendations and subsequent morbidity and mortality in the Iowa Women's Health Study cohort.Cancer Epidemiol Biomarkers Prev. 2004 Jul;13(7):1114-20. Cancer Epidemiol Biomarkers Prev. 2004. PMID: 15247121
-
Fracture incidence in relation to the pattern of use of hormone therapy in postmenopausal women.JAMA. 2004 May 12;291(18):2212-20. doi: 10.1001/jama.291.18.2212. JAMA. 2004. PMID: 15138243
-
Where are we with postmenopausal hormone therapy in 2005?Gynecol Endocrinol. 2005 Nov;21(5):248-56. doi: 10.1080/09513590500279733. Gynecol Endocrinol. 2005. PMID: 16373243 Review.
-
Indications for hormone therapy: the post-Women's Health Initiative era.Endocrinol Metab Clin North Am. 2004 Dec;33(4):691-715. doi: 10.1016/j.ecl.2004.07.008. Endocrinol Metab Clin North Am. 2004. PMID: 15501641 Review.
Cited by
-
Increased longevity in older users of postmenopausal estrogen therapy: the Leisure World Cohort Study.Menopause. 2006 Jan-Feb;13(1):12-8. doi: 10.1097/01.gme.0000172880.40831.3b. Menopause. 2006. PMID: 16607094 Free PMC article.
-
The association between a functional CYP1A1 polymorphism and colorectal neoplasia risk in post menopausal women.Dig Dis Sci. 2010 Oct;55(10):2965-70. doi: 10.1007/s10620-009-1105-9. Epub 2010 Jan 22. Dig Dis Sci. 2010. PMID: 20094781 Free PMC article.
-
Menopausal hormones and breast cancer in a biracial population.Am J Public Health. 2000 Jun;90(6):966-71. doi: 10.2105/ajph.90.6.966. Am J Public Health. 2000. PMID: 10846517 Free PMC article.
-
Age-specific effects of hormone therapy use on overall mortality and ischemic heart disease mortality among women in the California Teachers Study.Menopause. 2011 Mar;18(3):253-61. doi: 10.1097/gme.0b013e3181f0839a. Menopause. 2011. PMID: 20881652 Free PMC article.
-
Estrogen Therapy and Ischemic Stroke in Women with Diabetes Aged Over 55 Years: A Nation-Wide Prospective Population-Based Study in Taiwan.PLoS One. 2015 Dec 14;10(12):e0144910. doi: 10.1371/journal.pone.0144910. eCollection 2015. PLoS One. 2015. PMID: 26658781 Free PMC article.
References
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
